J. V. Krieken

H. Putter, C. V. D. van de Velde, J. D. de Vries, 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer. Prospective randomised trial with standard operative and histopathological techniques. Dutch ColoRectal Cancer Group.

C. V. D. van de Velde, T. Wiggers, J. Hermans, 1999, The European journal of surgery = Acta chirurgica.

Polymerase chain reaction-based clonality testing in tissue samples with reactive lymphoproliferations: usefulness and pitfalls. A report of the BIOMED-2 Concerted Action BMH4-CT98-3936

T. Molina, E. Schuuring, J. Dongen, 2007, Leukemia.

Liver injury in long‐term methotrexate treatment in psoriasis is relatively infrequent

J. Snoek, J. Drenth, E. D. De Jong, 2006, Alimentary pharmacology & therapeutics.

Increased epithelial cell proliferation in the ileal pouch mucosa of patients with familial adenomatous polyposis

I. Nagtegaal, F. Nagengast, W. Peters, 2007, Virchows Archiv.

Pathology data in the central databases of multicenter randomized trials need to be based on pathology reports and controlled by trained quality managers.

J Hermans, I. Nagtegaal, C. V. D. van de Velde, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases

I. Nagtegaal, M. Koopman, S. Teerenstra, 2010, British Journal of Cancer.

The Dutch surgical colorectal audit.

V. Lemmens, T. Wiggers, H. Rutten, 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Loss of Ep-CAM (CO17-1A) expression predicts survival in patients with gastric cancer

C. V. D. van de Velde, J. Hermans, J. V. van Krieken, 2005, British Journal of Cancer.

KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients

I. Nagtegaal, S. Teerenstra, L. Mekenkamp, 2011, British Journal of Cancer.

Local recurrence in patients with rectal cancer diagnosed between 1988 and 1992: a population-based study in the west Netherlands.

C. V. D. van de Velde, C. Marijnen, A. Colenbrander, 1998, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program

P. Jares, C. Langner, P. Quirke, 2008, Virchows Archiv.

Deficient mismatch repair system in patients with sporadic advanced colorectal cancer

M. Ligtenberg, M. Koopman, L. Mekenkamp, 2009, British Journal of Cancer.

Mechanisms of oncogenesis in colon versus rectal cancer

J. Hermans, E. Kranenbarg, R. Tollenaar, 2001, The Journal of pathology.

Prevalence of RAS mutations and individual variation patterns among patients with metastatic colorectal cancer: A pooled analysis of randomised controlled trials.

M. Peeters, V. Gastañaga, Aliki Taylor, 2015, European journal of cancer.

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.

W. Oyen, R. Labianca, W. Scheithauer, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

H. Putter, L. Påhlman, I. Nagtegaal, 2001, The New England journal of medicine.

Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial.

I. Nagtegaal, E. Noordijk, C. Marijnen, 2003, International journal of radiation oncology, biology, physics.

Prevalence of RAS mutations and individual variation patterns among patients with metastatic colorectal cancer: A pooled analysis of randomised controlled trials.

M. Peeters, V. Gastañaga, Aliki Taylor, 2015, European journal of cancer.

The role of pathologists in the quality control of diagnosis and treatment of rectal cancer-an overview.

I. Nagtegaal, J. V. van Krieken, J. V. Krieken, 2002, European journal of cancer.

RAS testing for colorectal cancer patients is reliable in European laboratories that pass external quality assessment

M. Ligtenberg, A. Siebers, J. V. Krieken, 2018, Virchows Archiv.

Psychological distress in newly diagnosed colorectal cancer patients following microsatellite instability testing for Lynch syndrome on the pathologist’s initiative

H. Brunner, M. Ligtenberg, F. Nagengast, 2012, Familial Cancer.

Variation in Lymph Node Evaluation in Rectal Cancer: A Dutch Nationwide Population-Based Study

V. Lemmens, S. Siesling, J. Langendijk, 2011, Annals of Surgical Oncology.

Large variation between hospitals and pathology laboratories in lymph node evaluation in colon cancer and its impact on survival, a nationwide population-based study in the Netherlands.

V. Lemmens, S. Siesling, O. Visser, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.